News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
BIO Asia Conference in Tokyo Cancelled Amid COVID…
Washington, DC – February 21, 2020 - The Biotechnology Innovation Organization (BIO) announced today, it is canceling the annual BIO Asia conference in Tokyo scheduled for March 10-11. The decision was based on the global impact of COVID-19 and…
A Patient Advocate’s Perspective on Foreign Price…
In a new video, Cynthia Bens, patient advocate and Senior Vice President of Public Policy at the Personalized Medicine Coalition, shares her views on how adopting foreign price controls for prescription medicines will impact patients in the U.S. …
Patients, Scientists and Researchers Will Be…
Ahead of tonight’s State of the Union Address, Jim Greenwood, President and CEO of the Biotechnology Innovation Organization, shared what he hopes President Trump will say to America’s patients counting on the development of new medicines and cures,…
Letters, Testimony, & Comments
21st Century Cures: BIO Comments on FDA Draft…
February 14, 2020 Re: Docket No. FDA–2020-D-0529: FDA Draft Guidance, Qualification Process for Drug Development Tools Dear Sir/Madam:  The Biotechnology Innovation Organization (BIO) thanks the Food and Drug Administration (FDA or Agency)…
Request to EPA for Analysis of Lifecycle Ethanol…
Dear Administrator McCarthy, We write to request that the Environmental Protection Agency (EPA) update its greenhouse gas life-cycle emissions analysis for corn ethanol to include consideration of the current state of the industry and the published…
Pediatrics: BIO Comments on FDA Draft Guidance on…
February 11, 2020 Re: Docket No. FDA–2019-D-4751: Food and Drug Administration Reauthorization Act Implementation Guidance for Pediatric Studies of Molecularly Targeted Oncology Drugs Dear Sir/Madam: The Biotechnology Innovation Organization (BIO…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Hanging light bulb
February 20, 2020
Since the beginning of time, production of any kind creates waste. From our gadgets, to our personal care, to our food, growth begets garbage. However, as the planet drowns in our own waste, researchers are finding new…
Scanning plants
February 14, 2020
On Sunday, February 16th, we celebrate #InnovationDay.  In virtually every technology and industry, innovation is seen as a positive. Eco-friendly cars, personalized medicine, virtual reality, and smart…
BIA
February 13, 2020
Since the earliest days of biotech, the UK and the USA have worked together to move science forward and build globally competitive companies.  James Watson (US) and Francis Crick (UK) worked together to solve the…